Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Cancer Chemotherapy and Pharmacology（2018）
摘要
The original version of this article unfortunately contained a mistake. The co-authors’ names were incorrect.
更多查看译文
关键词
bispecific antibody,egfr,ly3164530,cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要